Skip to main content
. 2023 Feb 8;33:7. doi: 10.1038/s41533-023-00330-1

Fig. 3. Approach to initial treatment in patients with asthma and/or COPD.

Fig. 3

GOLD Global Initiative for Obstructive Lung Disease, ICS inhaled corticosteroid, LABA long-acting β2 agonist; LAMA long-acting muscarinic antagonist. A summary of differentiating and diagnostic features in people with Asthma, COPD and Asthma + COPD. Source: Box 5–2 in GINA 2022. Reproduced with permission from ref. 11.